famotidine has been researched along with Cholestasis in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiménez-Sáenz, M | 1 |
| Argüelles-Arias, F | 1 |
| Herrerías-Gutiérrez, JM | 1 |
| Durán-Quintana, JA | 1 |
1 other study available for famotidine and Cholestasis
| Article | Year |
|---|---|
Acute cholestatic hepatitis in a child treated with famotidine.
Topics: Acute Disease; Adolescent; Chemical and Drug Induced Liver Injury; Cholestasis; Famotidine; Histamin | 2000 |